Chair: A. Winterstein
Interim Graduate Coordinator: R. Segal
Integral to the University of Florida’s Health Science Center, the Department of Pharmaceutical Outcomes and Policy offers a unique blend of research and training in patient safety, pharmacoepidemiology, pharmacoeconomics, and social-behavioral issues surrounding medication use.
Pharmaceutical Outcomes and Policy offers a broad spectrum of opportunities for training, including a residential PhD and a residential MS program, for students in the health and related sciences. Students can choose between several specialty areas and have the opportunity to immerse themselves in research early in their training with ongoing faculty research programs.
The Ph.D. degree provides individuals with the credentials to develop and direct clinical research units in universities, pharmaceutical companies and contract research organizations, and government organizations. Successful graduates have a range of technical and disciplinary competencies in research design, measurement, inferential statistics, the communication and evaluation of research, research ethics, healthcare delivery and the medication use system, the drug product, and behavioral and policy issues surrounding medication use. Those successful graduates of the residential MS degree who have a desire to continue their studies can apply for the Ph.D. program, with MS course work and other scholastic requirements applicable.
The Department has excellent facilities for quantitative and qualitative research, and faculty have been highly successful in attracting extramural research support. Qualitative research infrastructure includes conference facilities with state-of-the art equipment for focus groups or patient interviews. Quantitative research facilities include computer labs for students, a department-owned secure research server that houses various population-based datasets, and a variety of software packages.
For more information, please see the program page below and visit our website: http://pop.pharmacy.ufl.edu.
- Odedina, Folakemi G.
- Segal, Richard
- Winterstein, Almut Gertrud
- Xiao, Hong
- Park, Haesuk
- Brown, Joshua D.
- Diaby, Vakaramoko
- Hampp, Christian
- Lo Ciganic, Wei Hsuan Jenny
- Shao, Hui
- Wei, Yu-Jung
Clinical Assistant Professor
- Vouri, Scott M.
- Navarro, Robert P.
- Beck, Diane Elizabeth
PHARMACEUTICS DEPARTMENT COURSES
|PHA 6116||In Vivo and In Vitro Stability of Drugs||3|
|PHA 6125||Pharmacokinetics and Biopharmaceutics||3|
|PHA 6131||Pharmacometrics and Systems Pharmacology||3|
|PHA 6133||Translational Clinical Pharmacology||3|
|PHA 6170C||Pharmaceutical Product Formulation||3|
|PHA 6183||Pharmaceutical Gene Delivery||3|
|PHA 6185||Pharmaceutical Drug Development||3|
|PHA 6416||Pharmaceutical Analysis I||3|
|PHA 6418||Applied Translational Systems Pharmacology||3|
|PHA 6476||Advanced Combinatorial Chemistry in Drug Discovery||3|
|PHA 6630||Medication Therapy Management: A Hematologic Focus||3|
|PHA 6631||Foundations of Medication Therapy Management I||3|
|PHA 6632||Foundations of Medication Therapy Management II||3|
|PHA 6633||Medication Therapy Management: A Cardiovascular Focus||3|
|PHA 6634||Medication Therapy Management: An Endocrine Focus||3|
|PHA 6635||Medication Therapy Management: A Renal Focus||3|
|PHA 6636||Medication Therapy Management: A Gastrointestinal Focus||3|
|PHA 6637||Medication Therapy Management: A Psychiatric Focus||3|
|PHA 6638||Medication Therapy Management: A Neurologic Focus||3|
|PHA 6639||Medication Therapy Management: A Respiratory Focus||3|
|PHA 6894||Introduction to Graduate Studies||1|
|PHA 6896||Preclinical Drug Evaluation||2|
|PHA 6910||Supervised Research||1-5|
|PHA 6935||Selected Topics in Pharmacy||1-4|
|PHA 6936||Advanced Topics in Pharmaceutical Sciences||1-2|
|PHA 6938||Research Seminar||1|
|PHA 6940||Supervised Teaching||1-5|
|PHA 6971||Research for Master's Thesis||1-15|
|PHA 7979||Advanced Research||1-12|
|PHA 7980||Research for Doctoral Dissertation||1-15|